Hemang Naik’s Post

Excited to announce the launch of Compact CoVigilAI to suit smaller volumes of abstracts! Whether you are a small PV team or a large enterprise, we have tailor-made plans for you! To know more & avail the launch offer, reach out to us at LetsAI@CognifAI.in with your preferred dates and times for a quick discussion. Hemang Naik Romesh Sheth Diana Priyadharshini Jai Desai #GenerativeAI #PharmaCovigilance #QPPV #MedicalLiteratureMonitoring #CoVigilAI

Speed up your medical literature screening! If you're a small / large enterprise Life Science company and looking for augmenting ICSR literature screening using #GenerativeAI , then this easy-to-use solution #CoVigilAI is perfect. Find more details here - https://www.covigilai.in #CoVigilAI #CognifAI #PV #Pharmacovigilance #GenerativeAI #AI #Lifesciences #PatientSafety #Innovation #AdverseEvents #ICSR #MedicalLiterature #LiteratureScreening

Our webinar on “Establishing a safety framework for medical device trial” is about to start shortly. Join the expert Ms. Meredith Frank-Molnia, Senior Director, Clinical Operations, Third Pole Therapeutics as she discusses about: - Considerations in Selecting a Safety Vendor RFI/RFP process - Technology implementation - Difference between device and drug trials - Safety reporting for medical device - Investigator Responsibilities - Needed Safety Documentation - Safety Monitoring Committees - Blinding Consideration Don’t forget to register and join us, sign up now @ https://bit.ly/47INJpY #Soterius #Webinar #Therapeutics #MedicalDeviceTrial #PV #Pharmacovigilance #ClinicalPV #PVServices #drugtrials #clinicaltrials #drugsafety #clinicalsafety #clinicalresearch #LifeSciences

Discover the numerous advancements in #pharmacovigilance through an engaging slide presentation showcasing key historical #pv facts. Put your knowledge to the test! 👉https://ow.ly/ovFr50RAQ2l

Among the lowest hanging fruit in medicine today…the time is now for broad-scale adoption of pharmacogenomic testing implemented with pharmacist support, including coverage and reimbursement.

Evidence synthesis experts and methodologists, how would you answer the question posed? ❌No, it would not meet the standards that make a review systematic. ✅Yes, there are exceptions that could justify calling it a systematic review. Please comment your reply. #systematicreview #medicaldevices #pharmacovigilance #postmarketsurveillance #scholarlypublishing #evidencebasedmedicine #evidencebasedpractice Cochrane, The Campbell Collaboration

Wonderful to read READUS-PVs recommendations for streamlined and transparrent publishing of disproportionality findings in #pharmacovigilance. Hoping this will be widely adopted by authors, reviewers and publishers. https://lnkd.in/drwdksCe Here's my bite-sized summary:

We are excited about our next Oracle Safety Consortium Innovation Summit coming up on February 8-9 in Reston, Virginia, and you can find more information about the event in the links below. If you have an interest in joining us, let me know and happy to share more information with you. #pharmacovigilance #drugsafety #realworldevidence #rwe

🤓 Stay informed with exclusive #DrugSafety insights! 📄 Check out "Composite Plot for Visualizing Aminotransferase and Bilirubin Changes in Clinical Trials of Subjects with Abnormal Baseline Values" – a benefit for #ISoPMembers. 🌐 Access the article: https://lnkd.in/gCxAmTSp. Join ISoP now for more valuable content! #Pharmacovigilance 🔍📌